| Nov 24, 2020 | Saneca Pharmaceuticals - Profits & Sales | Chart | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 225% |
| Nov 24, 2020 | Saneca Pharmaceuticals - from EBITDA to Net Profit | Chart | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 225% |
| Nov 24, 2020 | Saneca Pharmaceuticals - from EBITDA to Net Profit | Chart | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 225% |
| Nov 24, 2020 | Saneca Pharmaceuticals - Profits & Sales | Chart | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 225% |
| Nov 24, 2020 | Saneca's price/earnings (P/E) remain unchanged yoy at -5.64 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 63% |
| Nov 24, 2020 | Saneca's price/earnings (P/E) remain unchanged yoy at -5.64 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 63% |
| Nov 25, 2020 | Saneca's ROCE remain unchanged yoy at -9.48% in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 38% |
| Nov 25, 2020 | Saneca's ROCE remain unchanged yoy at -9.48% in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 38% |
| Nov 24, 2020 | Saneca's Net Margin remain unchanged yoy at -6.26% in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 38% |
| Nov 24, 2020 | Saneca's Total Cash From Operations remain unchanged yoy at EUR -0.519 mil in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 38% |
| Nov 24, 2020 | Saneca's Net Margin remain unchanged yoy at -6.26% in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 38% |
| Nov 24, 2020 | Saneca's Total Cash From Operations remain unchanged yoy at EUR -0.519 mil in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 38% |
| Nov 24, 2020 | Saneca's Capital Expenditures remain unchanged yoy at EUR 3.69 mil in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
| Nov 24, 2020 | Saneca's Net Debt/EBITDA fell 241% yoy to -5.20 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
| Nov 24, 2020 | Saneca's Capital Expenditures remain unchanged yoy at EUR 3.69 mil in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
| Nov 24, 2020 | Saneca's Net Debt/EBITDA fell 241% yoy to -5.20 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
| Nov 24, 2020 | Saneca's P/FCF remain unchanged yoy at -4.82 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
| Nov 24, 2020 | Saneca's P/FCF remain unchanged yoy at -4.82 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
| Nov 24, 2020 | Saneca's Share Price remain unchanged yoy at EUR 20.3 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
| Nov 24, 2020 | Saneca's Share Price remain unchanged yoy at EUR 20.3 in 2019 | News | Slovakia | Pharmaceutical | Saneca Pharmaceuticals | 13% |
Helgi Library 
